Literature DB >> 24275268

Trichomoniasis: the "neglected" sexually transmitted disease.

Elissa Meites1.   

Abstract

Trichomonas vaginalis is the most prevalent nonviral sexually transmitted infection, affecting an estimated 3.7 million people in the United States. Although trichomoniasis is common, it has been considered a "neglected" sexually transmitted disease, due to limited knowledge of its sequelae and associated costs. This article reviews current epidemiology, pathophysiology, diagnostic methods, clinical management recommendations and special considerations, research on associated conditions and costs, prevention strategies, and controversies regarding trichomoniasis. Published by Elsevier Inc.

Entities:  

Keywords:  Nitroimidazoles; Nucleic acid amplification tests; Sexually transmitted disease; Trichomonas vaginalis; Urethritis; Vaginitis

Mesh:

Substances:

Year:  2013        PMID: 24275268      PMCID: PMC4677781          DOI: 10.1016/j.idc.2013.06.003

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  53 in total

1.  A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women.

Authors:  Patricia Kissinger; Leandro Mena; Judy Levison; Rebecca A Clark; Megan Gatski; Harold Henderson; Norine Schmidt; Susan L Rosenthal; Leann Myers; David H Martin
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12-15       Impact factor: 3.731

2.  Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens--a randomized clinical trial.

Authors:  J R Schwebke; A Rompalo; S Taylor; A C Seña; D H Martin; L M Lopez; S Lensing; J Y Lee
Journal:  Clin Infect Dis       Date:  2011-01-15       Impact factor: 9.079

3.  Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial.

Authors:  Jane R Schwebke; Marcia M Hobbs; Stephanie N Taylor; Arlene C Sena; Michael G Catania; Barbara S Weinbaum; Ann D Johnson; Damon K Getman; Charlotte A Gaydos
Journal:  J Clin Microbiol       Date:  2011-09-21       Impact factor: 5.948

4.  Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples.

Authors:  James P Hughes; Jared M Baeten; Jairam R Lingappa; Amalia S Magaret; Anna Wald; Guy de Bruyn; James Kiarie; Mubiana Inambao; William Kilembe; Carey Farquhar; Connie Celum
Journal:  J Infect Dis       Date:  2012-01-11       Impact factor: 5.226

5.  Ongoing sexually transmitted disease acquisition and risk-taking behavior among US HIV-infected patients in primary care: implications for prevention interventions.

Authors:  Kenneth H Mayer; Timothy Bush; Keith Henry; Edgar T Overton; John Hammer; Jean Richardson; Kathy Wood; Lois Conley; John Papp; Angela M Caliendo; Pragna Patel; John T Brooks
Journal:  Sex Transm Dis       Date:  2012-01       Impact factor: 2.830

6.  Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis infections in men with nongonococcal urethritis: predictors and persistence after therapy.

Authors:  Arlene C Seña; Shelly Lensing; Anne Rompalo; Stephanie N Taylor; David H Martin; Laureen M Lopez; Jeannette Y Lee; Jane R Schwebke
Journal:  J Infect Dis       Date:  2012-05-21       Impact factor: 5.226

7.  Are maternal genitourinary infection and pre-eclampsia associated with ADHD in school-aged children?

Authors:  Joshua R Mann; Suzanne McDermott
Journal:  J Atten Disord       Date:  2010-09-13       Impact factor: 3.256

8.  Trichomonas vaginalis genital infections: progress and challenges.

Authors:  Laura H Bachmann; Marcia M Hobbs; Arlene C Seña; Jack D Sobel; Jane R Schwebke; John N Krieger; R Scott McClelland; Kimberly A Workowski
Journal:  Clin Infect Dis       Date:  2011-12       Impact factor: 9.079

9.  Comparison of Aptima Trichomonas vaginalis transcription-mediated amplification assay and BD affirm VPIII for detection of T. vaginalis in symptomatic women: performance parameters and epidemiological implications.

Authors:  Sarah B Andrea; Kimberle C Chapin
Journal:  J Clin Microbiol       Date:  2011-01-19       Impact factor: 5.948

10.  Trichomonas vaginalis antimicrobial drug resistance in 6 US cities, STD Surveillance Network, 2009-2010.

Authors:  Robert D Kirkcaldy; Peter Augostini; Lenore E Asbel; Kyle T Bernstein; Roxanne P Kerani; Christie J Mettenbrink; Preeti Pathela; Jane R Schwebke; W Evan Secor; Kimberly A Workowski; Darlene Davis; Jim Braxton; Hillard S Weinstock
Journal:  Emerg Infect Dis       Date:  2012-06       Impact factor: 6.883

View more
  8 in total

1.  Why Does Trichomonas vaginalis Continue to be a "Neglected" Sexually Transmitted Infection?

Authors:  Christina A Muzny
Journal:  Clin Infect Dis       Date:  2018-07-02       Impact factor: 9.079

2.  Is It Time to Stop Using Single-dose Oral Metronidazole for the Treatment of Trichomoniasis in Women?

Authors:  Christina A Muzny; Saralyn Richter; Patricia Kissinger
Journal:  Sex Transm Dis       Date:  2019-05       Impact factor: 2.830

3.  The incidence of Trichomonas vaginalis infection in women attending nine sexually transmitted diseases clinics in the USA.

Authors:  Maria L Alcaide; Daniel J Feaster; Rui Duan; Stephanie Cohen; Chanelle Diaz; Jose G Castro; Matthew R Golden; Sarah Henn; Grant N Colfax; Lisa R Metsch
Journal:  Sex Transm Infect       Date:  2015-06-12       Impact factor: 3.519

Review 4.  A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.

Authors:  Elissa Meites; Charlotte A Gaydos; Marcia M Hobbs; Patricia Kissinger; Paul Nyirjesy; Jane R Schwebke; W Evan Secor; Jack D Sobel; Kimberly A Workowski
Journal:  Clin Infect Dis       Date:  2015-12-15       Impact factor: 9.079

Review 5.  Trichomoniasis - are we giving the deserved attention to the most common non-viral sexually transmitted disease worldwide?

Authors:  Camila Braz Menezes; Amanda Piccoli Frasson; Tiana Tasca
Journal:  Microb Cell       Date:  2016-06-27

6.  A pilot study on Trichomonas vaginalis in women with recurrent urinary tract infections.

Authors:  Po-Chih Chang; Yu-Chao Hsu; Ming-Li Hsieh; Shih-Tsung Huang; Hsin-Chieh Huang; Yu Chen
Journal:  Biomed J       Date:  2016-09-16       Impact factor: 4.910

7.  Comparative analysis of syndromic and PCR-based diagnostic assay reveals misdiagnosis/ overtreatment for trichomoniasis based on subjective judgment in symptomatic patients.

Authors:  Subash Chandra Sonkar; Kirti Wasnik; Anita Kumar; Pratima Mittal; Daman Saluja
Journal:  Infect Dis Poverty       Date:  2016-05-05       Impact factor: 4.520

8.  Survey of Obstetrician-gynecologists in the United States About Trichomoniasis, 2016.

Authors:  Eugene W Liu; Kimberly A Workowski; Laura H Taouk; Jay Schulkin; William E Secor; Jeffrey L Jones
Journal:  Sex Transm Dis       Date:  2019-01       Impact factor: 2.830

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.